Company Profiles

driven by the PitchBook Platform

Acylin Therapeutics

Acylin Therapeutics
2009 FOUNDED
PRIVATE STATUS
2ndary - Private LATEST DEAL TYPE
$1.04M LATEST DEAL AMOUNT
$4.4M TOTAL AMOUNT RAISED
6 INVESTORS
Description

Developer of drugs designed to provide cancer treatment. The company's drugs help to cure cancer, tumors and other inflammatory diseases, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
1616 Eastlake Avenue
Suite 203
Seattle, WA 98102
United States

+1 (206) 957-7300
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acylin Therapeutics’s full profile, request a free trial.

Acylin Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 02-Jul-2014 $1.04M $4.4M 00.000 Completed Generating Revenue
3. Early Stage VC (Series A1) 22-May-2012 000 00.00 000.00 Completed Startup
2. Early Stage VC (Series A) 01-Dec-2010 $2.4M $2.4M $6.8M Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Acylin Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00.00 00 00 00 00 00.000
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

Acylin Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accelerator Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Fast Forward at Johns Hopkins University Accelerator/Incubator 000 0000 000000 0
OVP Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Acylin Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Suresh Jain Ph.D Co-Founder, President & Chief Operating Officer

Acylin Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Carl Weissman Accelerator Board Member 000 0000
Chad Waite Jr. OVP Venture Partners Board Member 000 0000
Lee Babiss Ph.D Pharmaceutical Product Development Board Member 000 0000
Lindsay Rayle Accelerator Board Member 000 0000
Peter DiStefano Ph.D Self Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »